AI
Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.
At HIMSS23, panelists discussed health systems' financial challenges as labor costs rise and the population ages.
Also, Omron Healthcare India is launching a remote heart health management platform with AI company Tricog.
It is making further moves to penetrate the Southeast Asian market.
Olive said the deal completes its pivot to focus on health system finances.
They will deploy AI to help reduce delays and gaps in stroke care management.
Its latest funding will also go to building new capabilities.
Also, Roche and Astellas have combined their diabetes management solutions.
The company targets to receive a similar clearance from the US FDA by yearend.
It has been approved for use in both clinical and home settings.